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Abstract
Central line-associated bloodstream infections (CLABSIs) are responsible for 100,000
patient deaths per year, creating a critical need for prevention of these deadly infections
that occur with central venous lines (CVLs). Alternative forms of IV access such as
midline catheters (MLCs) may offer lower rates of infection than those seen with CVLs.
MLCs were implemented at the practice setting in 2016; however, no evaluation of their
effectiveness had been conducted. The purpose of this project was to evaluate the
effectiveness of MLCs using a retrospective, pre- post- comparison of CLABSI rates and
device utilization rates (DUR) obtained from the practice setting before and after
implementation of MLCs. Infection control and Lewin’s change theories were used to
provide a foundation for the project. This retrospective, pre-post comparison of CLABSI
and DUR 6 months before and after introduction of MLCs sought to determine if MLC
use affected either rate. Results of a Wilcoxon signed-rank test showed no statistical
differences (p > .05) in CLABSI rates and DUR when comparing the rates from the
specified 6 month periods. A secondary purpose was to identify the characteristics and
conditions in which MLCs were used. Patients with cardiovascular, neuro, and infection
diagnoses constituted 43% of the 262 MLC placements. No statistically significant
improvement in infection rates was demonstrated by this project; however, these findings
illuminate the types of patients or conditions where MLCs are a viable alternative for IV
access, and this knowledge may assist providers in options for patient care. This project
promotes positive social change by raising awareness of potential strategies for reducing
infections in patients when they are at their most vulnerable.
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Section 1: Overview of the Evidence-Based Project
Introduction
Healthcare-associated infections (HAIs), particularly central line-associated
bloodstream infections (CLABSIs), constitute some of the most costly complications of
hospital inpatient stays in the United States and the world. The need to prevent HAIs is
recognized nationally and in the local health system as a problem that requires a
coordinated effort to identify the risks and to strategize about ways to reduce the risk.
Section 1 of this study will cover the following topics: introduction to the project, a
problem, purpose, nature of the project, significance and implications for social change.
HAIs, particularly CLABSIs, are some of the most costly inpatient complications.
The estimated cost for a CLABSI incident is high: $32,254 (Dawson & Moureau, 2013).
The cost in terms of patient mortality is also high: approximately 100,000 patient deaths
per year (Dick et al., 2015). Not only is the cost high, but more importantly the burden of
illness takes a tremendous toll on patients and their families. Prevention of CLABSIs can
save lives, decrease unnecessary morbidity, prevent loss of income to hospitals, and
could save taxpayers and insurers millions of dollars (Scott et al., 2014). A number of
published articles describe populations of patients, such as those with cystic fibrosis, who
may benefit from use of MLCs (Adams, Little, Vinsant, & Khandelwal, 2016;
Cummings, Hearse, McCutcheon, & Deuter, 2011; Giuliani et al., 2013); however, only a
few articles were identified that describe patients in the general population who have had
a MLC inserted (Moureau, Sigl, & Hill, 2015). Yet, deciding to use a MLC over other

2
forms of IV access must be an informed decision meaning benefits as well as risks should
be considered in each case for each patient. Therefore, in this study I will describe the
patients in one health system where MLCs were the preferred vascular access device
(VAD) for intermediate length of time IV therapy, with a focus on decreasing rates of
CLABSIs and device utilization rates (DUR), the measure of how long a central venous
line (CVL) remains in a central blood vessel, for those patients.
Problem Statement
The high rate of preventable HAIs, specifically CLABSIs, results in high cost for
prolonged hospitalizations, increased use of limited resources, and high morbidity and
mortality for patients (Scott et al., 2014). The CLABSI rate in one Southeastern Level I
Trauma Center teaching hospital is greater than the national average (Centers for Disease
Control and Prevention [CDC], 2016). Numerous strategies were offered to reduce the
rate of CLABSIs, including the use of MLCs, but in this health system little was known
about how the MLCs performed in reducing CLABSI rates or which patients might
benefit the most from their use. This doctoral project sought to compare CLABSI rates
and DURs 6 months prior and 6 months after initiation of MLC use. The goal was to
determine if there was a difference in infection rates and DUR after beginning the use of
MLCs.
Purpose Statement
The purpose of this quantitative comparison project was to examine CLABSI
rates and DUR and to identify the characteristics of patients who would be candidates for
a MLC. The objective was to evaluate the impact of adding MLC use for eligible patients

3
on CLABSI rates in one Southeastern Level I Trauma Center teaching hospital by
evaluating the DUR for CVLs and describing the characteristics of patients who received
them. MLCs have been in place for 9 months in this facility. In this project a
retrospective comparison of CLABSI rates and DURs for a 6-month period before the
MLCs were available and then 6 months after they were available was conducted.
Characteristics of patients receiving MLCs were described. This project is significant to
practice because it can help avoid CLABSIs and thus prevent patient complications,
expense, and potential loss of life. Quality care can save costs and prevent complications
(Raschka, Dempster, & Bryce, 2013). This project addressed two questions: In a
retrospective review of 6 months before and 6 months after implementation of MLCs did
the CLABSI and DUR rates decrease? What are the characteristics of patients who
received MLCs? This project can help to determine whether MLCs have been useful in
decreasing CLABSI rates and DURs as well as providing a description of patients who
have received MLCs.
Nature of the Problem
CLABSIs are one of the most costly HAIs and are largely preventable by
adhering to evidence-based guidelines of care and protocols (Kusek, 2012). Retrospective
data for this project were obtained from monthly infection control measure reports that
were sent to the CDC. Statistical analysis comparing the two 6-month periods, one before
MLCs and one after the MLCs was performed using SPSS software. A retrospective
report with patient demographics for all patients receiving MLCs was analyzed for
descriptive characteristics. Gathering characteristics of patients who have received MLCs
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may help clinicians to more quickly identify patients in various settings, such as the
emergency department (ED), who would benefit from use of this type of VAD (Adams et
al., 2016; Dumont, Getz, & Miller, 2014). This DNP project sought to determine if the
use of MLCs affected CLABSI and DUR rates. It also sought to describe the
characteristics of patients who have received MLCs.
Significance of the Project
The Southeastern Level I Trauma Center and teaching hospital provides care for
many patients in seven specialized intensive care units (ICUs) who require CVLs.
Stakeholders in the process of insertion and care of CVLs were: patients, IV therapy team
members, nurses, physicians, infection control specialists, educators, administrators,
financial analysts, buyers, pharmacists, advanced practice registered nurses (APRNs),
surgeons, occupational therapists, physical therapists, home health nurses and aides, and
surgery personnel. These devices are often essential for the initial treatment of ICU
patients. When transferred from the ICU, the CVL may be replaced with a more
appropriate device that provides IV access but does not require repeated venipunctures if
IV therapy is needed for more than 5 days but less than 4 weeks (Rosenthal, 2008). The
evidence –based significance of the project is that MLCs provide a VAD for intermediate
length intravenous (IV) therapy (Anderson, 2004). MLCs have advantages over short (1
inch) peripheral intravenous (PIV) catheters and central lines. The advantages include
better hemodilution and longer in-dwelling time due to the use of the large veins of the
upper arm. The blood flow in larger vessels allow medication to be diluted in a larger
amount of faster flowing blood as it is infused through the MLC, thus altering the pH and
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osmolality and making phlebitis less likely (Anderson, 2004, p.314). Because MLCs are
placed in a larger vessel and are 7 to 8 inches long, they can remain in place for up to 28
days (Alexandrou et al., 2011, p.36). MLCs are VADs that provide a viable alternative
for IV therapy between short PIVs and central lines (Moureau & Chopra, 2016). The
potential contributions of this project to nursing are (a) a better understanding of MLCs in
the role of prevention of CLABSI and (b) a description of the characteristics of patients
who have received midlines. These descriptions and the findings from this project could
be used throughout the healthcare system; they could also be presented to a wide
audience via poster presentation or published article.
Implications for Social Change
The two strongest implications for social change in this project are the cost
savings in preventing CLABSIs and having a device that provides for intermediate-length
IV therapy. Prevention of HAIs and CLABSIs has an economic impact of “net benefits
per case averted ranging from $15,780 to $24,391” (Scott et al., 2014, p. 1040). MLCs
have the ability to be left in place for up to 28 days, which decreases the costs and pain
for patients by avoiding multiple IV sticks for PIVs. MLCs also facilitate and expedite
transfers to other healthcare facilities such as rehab units, nursing homes, or home for
outpatient care (Alexandrou et al., 2011).
Limitations of this project include the fact that few outcome studies have
compared the complications of MLCs with other VADs (Cummings et al., 2011). Some
articles cite the characteristics of patients with specific disease processes as benefiting
from MLC use, but no study has described the characteristics of a large group of patients
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with MLCs (Anderson, 2004; Moureau et al., 2015). MLC infection rates and
complications are not reported on a national level, but may be monitored in various ways
in individual facilities.
Summary
This project aims to make clinicians aware the role of MLCs in patient care and
where it can be used in the spectrum of VADs. The problem addressed in this study is the
high rate of CLABSI and DUR rates in one hospital facility. CLABSI are one of the most
costly hospital complications, but are preventable by using other VADs when feasible
and adherence to quality care guidelines. The retrospective qualitative comparison of
CLABSI and DUR rates 6 months prior and 6 months after the start of using MLCs in
this hospital facility sought to determine the impact of this intermediate time limited
VAD. The use of MLCs for appropriate patients and therapies may impact treatment
costs by prevention of complications. The characteristics of patients who have received
MLCs may contribute to population health by understanding how MLCs can be used in
various situations and with various patients. Chapter 2 will provide the historical
background of MLCs, the context for their use, and how information gained from this
information could benefit nursing practice and the care of patients.
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Section 2: Background and Context
Introduction
The high rates of HAIs, specifically CLABSIs, are a major problem that many
hospitals face; studies to examine prevention strategies are needed. The purpose of this
project was to examine CLABSI rates, which are a measure of central line infections and
DUR, which reflect the use of MLCs. The objective was to identify ways to decrease the
rate of CLABSIs in one hospital and to identify the characteristics of patients who
benefited from MLCs. The practice-focused questions for the project were: In a
retrospective review of 6 months before implementation of MLCs and 6 months after
implementation did the CLABSI rate and DUR decrease? What are the characteristics of
patients who received MLCs?
Concepts, Models, and Theories
A gap in knowledge regarding MLCs was identified by a needs assessment at the
health system where the use of MLCs as an option for vascular access was implemented.
Staff were reluctant to use the new MLCs and learn new techniques for care of this
device compared to peripherally inserted central lines (PICCs) which had been in place
for some time in the health system. Therefore, a need for a systematic process to
promote change was identified. The conceptual model used in this project was Lewin’s
(1951) change theory which is ideal for guiding a change in practice; it includes an
assessment of the forces driving and restraining the change. The change in practice
occurs when a new equilibrium is achieved by balancing the opposing forces (McEwen
& Willis, 2014). Lewin’s (1951) model of change is composed of three phases:
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unfreezing, moving, and refreezing. The driving forces were the need to decrease
CLABSI rates, DUR, and the availability of MLCs, a new device, for patient care. The
restraining forces were lack of knowledge about the use and care of MLCs. The
unfreezing stage was PICCs were replacing CVLs and higher than desired CLABSIs and
DURs were noted. MCLs were introduced to the hospital, which precipitated the moving
phase during which education for the new device was completed. The refreezing stage
occurred with MLCs being placed for IV access to replace CVLs and some PICCs. A
quality initiative to measure continued competence with MLCs was introduced into the
annual skills day to maintain the refreezing phase and ensure driving and restraining
forces have reached equilibrium (White & Dudley-Brown, 2012).
The theory of infection control was introduced by Dr. Ignaz Semmelweis, when
he showed how the spread of infection from a post mortem body to a patient could be
prevented with good hand hygiene (Gould, 2010, p. 275). The first physicians to observe
similar spread of diseases were Dr. Alexander Gordon, an obstetrician, and Dr. Oliver
Wendell Holmes, both of whom had published pamphlets on the spread of puerperal
infection prior to Dr. Semmelweis’ theory (Gould, 2010). Over the last decade, the
increase in HAIs has necessitated a resurgence in efforts to adhere to infection and
prevention control (IPC) principles and protocols (Edwards et al., 2012). Changing
health care providers’ adherence to IPC has been successful using the social marketing
behavior change framework. This framework has tenets in psychological theory,
persuasion psychology, and marketing; the idea is to promote a permanent change in
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hand hygiene and other steps to follow for promoting infection control and thus prevent
HAIs (Edwards et al., 2012).
Relevance to Nursing Practice
MLCs have been in existence since the 1950s when they were first used for
patient care. In the 1990s, MLCs raised concerns due to the material used in
manufacturing causing hypersensitivity in some patients (Alexandrou et al., 2011). MLCs
recently have returned to clinical practice after materials used in manufacturing changed.
Now the new product may provide advantages over other types of VADs. Some of the
advantages to MLCs are: they provide longer indwelling time, up to 28 days according to
the IV Nurses Society (2016), and IV access for patients with difficult IV access
(Griffiths, 2007; Maki, Kluger, & Crinch, 2006; Moureau & Chopra, 2016). MLCs are
peripheral catheters placed in one of the larger veins in the upper arm but with the tip
ending prior to axillary vein (Alexandrou et al., 2011; Rosenthal, 2008). The problem in
nursing being addressed by this project is higher than desired CLABSI and DUR rates.
Most CLABSIs are preventable when proper insertion techniques and protocols are
followed (Hsu, 2014; Matocha, 2013).When a care bundle is used consistently by nursing
staff CLABSI rates will decrease (Matocha, 2013). MLCs provide another option to
CVLs when an intermediate duration of IV therapy is needed (Dawson & Moureau, 2013;
Moureau & Chopra, 2016). One strategy to prevent CLABSI is to promptly remove
CVLs when no longer required for therapy (Bianco et al., 2013) and to choose an
appropriate catheter for continued therapy (Griffiths, 2007; O’Grady et al., 2011). The
goal of the CDC is to decrease HAIs to protect and promote patient safety (CDC, 2016).
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MLCs offer a reliable means for vascular access for up to four weeks and their use is
consistent with CDC recommendations for strategies to prevent CLABSIs. These
catheters have a decreased risk for infections and other complications found more often
in CVLs and PICCs (Moureau et al., 2015, p. 180). Describing characteristics of patients
who have received MLCs may enable clinicians to more quickly identify those who may
benefit from use of this VAD and preserve vessel health (Moureau et al., 2015, p 180).
Local Background and Context
The Southeastern Level I Trauma Center and teaching hospital provides care for
critically and acutely ill patients often requiring CVLs to administer needed fluids,
medications, or nutrition. The CLABSI rate and DUR were at higher than desired rates
causing prolonged lengths of stay, increasing patient care costs, increasing use of
resources, and decrease in patient satisfaction. A potential increase in mortality was a
concern because of increased complications. The CDC has targeted a decrease in
CLABSIs since the 1960s (Scott et al., 2014). One of the goals for the hospital is to
decrease CLABSI rates and DUR (O’Grady et al., 2011). The benefit of decreased
CLABSIs and DUR are savings in patient care costs, increased patient safety, and
increased patient satisfaction (Dick et al., 2015; Scott et al., 2014). CLABSI rates and
DUR are reported to the CDC by the hospital. For every patient diagnosed with a
CLABSI, the unit nursing staff and infection control director perform a chart review to
determine the exact cause of the infection and to understand steps to prevent further
infections. MLCs offer a part of the solution to the problem (Dawson & Moureau, 2013).
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Terms
The following terms were defined as follows for the current project.
Central Venous Catheter is a tube or catheter placed in a large central venous
blood vessel to deliver medications, fluids, and may remain in place for weeks to years.
Some types of these catheters are contained entirely within the body and must be
accessed with a needle. Other types have a portion of the ends of the catheter outside the
skin.
Central Line Associated Blood Stream Infection is a bloodstream infection caused
by the placement of a tube or catheter in a large central blood vessel.
Device Utilization Rate is a measure of how long a central venous catheter is in
place in a central blood vessel.
Healthcare-Associated Infection is an infection a patient receives while in the
hospital or healthcare facility.
Midline Catheter is a tube or catheter placed in one of the large veins in the upper
arm with the end of the catheter remaining in the peripheral blood vessel not extending
into the central blood vessel. This catheter is used for medications, fluids, and may
remain in place for up to 28 days.
Peripherally Inserted Catheter is a tube or catheter that is placed in one of the
veins of the fingers, hands, arms, feet, or legs that does not extend into a central blood
vessel. This catheter is used for medications, fluids, and may remain in place for up to 96
hours.
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Vascular Access Device is and tube or catheter that is placed in a vein or artery
and may be in a peripheral or central blood vessel.
Role of the DNP Student
The DNP student has been affiliated with the hospital for over 25 years and has
been a part of the growth and development of the hospital into a hospital system with
numerous hospitals, nursing home facilities, home health agencies, and an insurance
agency. The DNP student has been a direct patient care provider for critically ill patients
for most of those years and has participated in many initiatives to improve patient care.
CLABSIs are a safety issue to patients and can be reduced to almost zero if evidencedbased care is provided consistently (Moureau et al., 2015). MLCs have been introduced
into this hospital system as a whole within the last year. Due to the acuity of the patients
in this Southeastern Level I Trauma Center and teaching hospital, IV access is difficult to
obtain for some patients. Prior to MLCs, the choices for vascular access were central line
catheters consisting of CVLs with multiple lumens or peripherally inserted central
catheters (PICCs) or peripheral IVs (PIV) that had to be changed every 3 or 4 days if they
lasted that long. MLCs offer an intermediate therapy device as it can remain in place for
up to 28 days and is a long PIV that can allow staff to discontinue CVLs when not
needed.
The student’s role in the DNP Project was to determine if MLC use has had an
effect on CLABSIs and DUR. The second part of the project was to describe the patients
who have had MLCs placed. The DNP student worked with the IV team to observe how
MLCs are placed and how the nursing staff has adapted their practice to these new
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devices. The student reviewed clinical information to understand why patients may or
may not be candidates for MLC placement. The DNP student created a needs assessment
and took a lead in educating the nursing staff about MLCs. Some differences were
discovered in expenses and care of MLCs with other hospitals in the system.
Interestingly, a number of patients that have had MLCs placed and have to be readmitted,
have requested for them to be placed again.
Summary
CLABSIs are a major problem in healthcare facilities. Prevention strategies are
the best way to avoid infections and the complications that accompany them. One
strategy adopted by the Southeastern Level I Trauma Center teaching hospital was to
replace CVLs with other types of VADs including MLCs. The staff was unfamiliar with
the differences in insertion techniques and care of MLCs as compared to other VADs.
Lewin’s (1951) change theory and Semmelweis’ theory of IPC were used to guide the
evidence-based change in practice. MLCs, although available for many years, are starting
to be used in practice again due to manufacturing processes using new materials for the
catheters. The role of the student was to lead the initiative to improve patient care by
examining the role of MLCs in patient care. MLCs offer an alternative solution to
vascular access for the appropriate patient and may help to decrease CLABSIs and DUR.
Section 3 describes the data collection and the evidence about use of MLCs on CLABSIs,
DUR, and patient characteristics.
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Section 3: Collection and Analysis of Evidence
Introduction
MLCs have been introduced into practice in the Southeastern Level I Trauma
Center and teaching hospital in the last year. The DNP project sought to determine if
MLCs have had an effect on CLABSI and DUR. The secondary goal was to describe
patients who receive MLCs to determine if there are certain characteristics that are used
in this setting and are common to patients where MLCs were used. MLCs have been
available for many years but recently started to be used in practice again due to new
manufacturing practices. MLCs may offer an alternative solution to vascular access for
the appropriate patient and may help to decrease CLABSIs and DUR. The next section
will review the approach used to determine the effect of MLCs on CLABSIs and DUR.
Section three discusses the practice-focused questions, sources of evidence, and the
analysis and synthesis plan.
Practice-Focused Questions
The high rate of preventable HAIs, specifically CLABSIs, results in high cost for
prolonged hospitalizations, increased use of limited resources, and high morbidity and
mortality for patients (Scott et al., 2014). The CLABSI rate in one Southeastern Level
I Trauma Center teaching hospital was greater than the national average (CDC, 2016).
Numerous strategies had been offered to reduce the rate of CLABSIs, including the
use of MLCs, but in this health system little was known about how the MLCs perform
in reducing CLABSI rates. This project sought to compare CLABSI rates and DURs,
6 months prior to and 6 months after initiation of MLC use, to determine if there was
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a difference in infection rates and DUR after beginning the use of MLCs. The
purpose of this quantitative comparison project was to examine CLABSI rates and
DURs and to describe the characteristics of patients who received MLCs (Zerla et al.,
2015). The objectives were to evaluate the impact of implementation of MLCs on
CLABSI rates in one Southeastern Level I Trauma Center teaching hospital by
evaluating the DUR for CVLs and MLC in appropriate patients. MLC use has been in
place for 9 months in this facility. A retrospective comparison of CLABSI rates and
DURs was conducted; the comparison included the 6-month period before the MLCs
were available and 6 months after they became available. Characteristics of patients
receiving MLC were described.
This project is significant to practice because it is expected to help avoid
treatment patient complications, expense, and potential loss of life by avoiding
CLABSIs. Quality care can save costs and prevent complications (Raschka et al.,
2013).
1. In a retrospective review of 6 months before implementation of MLCs and 6
months after, did the CLABSI rate and DUR decrease?
2. What are the characteristics of patients who received MLCs?
Sources of Evidence
Evidence was gathered from two sources of reports: various nursing units and the
infection control department. These were all created to report monthly CLABSI rates and
DUR are forwarded to the CDC. The infection control department is responsible for the
completeness and accuracy of this report for the CDC. Electronic medical records were
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retrospectively queried for age, sex, admission diagnosis, pertinent history, medical or
surgical treatment for the focus admission, and purpose for placement information that
was collected to describe patients who received MLCs. A report was generated from the
electronic medical record (EMR) for purposes of this project. Only the above mentioned
information was collected according to independently numbered documents maintained
by the IV therapy team. The report had no patient identifiers. Each data line was kept
together (age, sex, admission diagnosis, pertinent history, medical or surgical treatment
for the focus admission, and purpose for placement). The data for this report were entered
into the computer for regular patient admissions to the hospital by nurses and admitting
personnel. The limitations inherent to these data are there may be duplicate terms used or
omitted. The data may not be complete for every individual who received a MLC.
Search engines EBSCOhost, ProQuest, CINAHL, MEDLINE, and Science Direct
were used to provide evidence for comparisons and further insights into the findings of
the project. Additionally, to translate the findings to practice, evidence from the literature
and from professional organizational websites, such as the CDC, will be used to develop
a plan for dissemination of the findings.
Protection of Participant Information
Before beginning the project, the student applied for IRB approval from the
Walden IRB number 01-30-17-0598716. In addition, the hospital required an application
for their site specific IRB (Eastern Virginia Medical School IRB number 17-01-NH0019), presentation of the project proposal to the nursing research committee (NRC), and
permission from the chief nursing officer (CNO). Application to the local IRB was
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completed. Presentations were made to the NRC and permission was requested from the
CNO. All applications and permissions were approved. The site IRB determined that due
to the retrospective and de-identified nature of the data, this DNP project “did not involve
human subjects” and thus was not subject to further IRB review. The hospital served as
the IRB of record for the project and the Walden IRB served as the IRB for the analysis
of the student’s work. Protection of human rights were maintained in this project as no
patient identifiers were gathered as data. All data for this project is being maintained in a
password-protected file in the DNP student’s home computer for 2 years or longer as
required by the IRB. No one but the student will have access to the information. After the
designated time frame is passed the data will be destroyed.
Analysis and Synthesis
Analysis of the data has been performed using SPSS software. The data has been
collected from the demographic information such as age and gender entered into the
computer system when the patient is admitted into the hospital. Data was collected
including: admission diagnosis, pertinent history, medical or surgical treatment for
current admission, and purpose for placement information. This report was generated
from the electronic medical record. No specific patient identifiers were captured on the
report. The Mann-Whitney U test was planned to be used to test the difference in the
comparison of the CLABSI rate and DUR for 6 month pre and post MLC implementation
(Polit, 2010). The best statistical test to compare the two related entities of CLABSI rates
and DUR is the Wilcoxon signed-rank test because the scores have come from the same
sources (Field, 2013). Descriptive statistics were used to identify frequency distributions
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for diagnoses, history, and treatments for patients who received MLCs. The DNP student
used SPSS software to perform the statistical analysis of the data. Synthesis of findings
have been completed by the student using the descriptive and demographic data collected
and the results of the Wilcoxon signed-rank test. The integrity of the data has been
maintained by keeping each line of data points together on one spread sheet (Grove,
Burns & Gray, 2013).
Summary
The practice-focused questions for this study were: In a retrospective review of 6
months before implementation and 6 months after, did the CLABSI rate and DUR
decrease? What are the characteristics of patients who received MLCs? Search engines
such as EBSCOhost, ProQuest, CINAHL, MEDLINE, and Science Direct were used to
gather evidence for this study. The sources of evidence were gathered by a retrospective
review of CLABSI rates and DUR reports from the nursing units and the infection control
department for 6 months prior and 6 months post implementation of MLCs. A
retrospective chart review of demographic information obtained by a de-identified report
from the EMR was gathered to describe all patients who received MLCs from Jan – June,
2016. Human subjects protections were maintained by obtaining IRB approvals from
Walden IRB, the hospital local IRB, and de-identified reports generated from electronic
medical records. SPSS was the statistical package used to analyze the data. The Wilcoxon
signed-rank test was used to analyze CLABSI rates and DUR. Descriptive statistics were
used to identify frequency distributions for diagnoses, history, and treatments for patients
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who received MLCs. Section 4 provides findings and recommendations from this
comparison and description of patients.
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Section 4: Findings and Recommendations
Introduction
The local problem is HAIs particularly CLABSIs are some of the most costly and
potentially deadly complications of hospital inpatient care (Dawson & Moreau, 2013).
The CLABSI rate at one Southeastern Level I Trauma Center teaching hospital was
greater than the national average (CDC, 2016). The gap in practice is that little is known
about how MLCs perform in decreasing CLABSI or the characteristics of patients who
might benefit from their use. The two practice-focused questions were as follows: (a) In a
retrospective study of 6 months before and 6 months after implementation of MLCs, did
the CLABSI rate and DUR decrease? (b) What are the characteristics of patients who
received MLCs?
The purpose of the doctoral project was to quantitatively examine CLABSI rates
and DUR and to identify characteristics of patients who received MLCs and thus be able
to determine those future candidates for MLC insertion. The sources of evidence included
reports gathered from nursing units and from infection control department reports. These
reports were created by the infection control department to report CLABSI rates and
DUR monthly to the CDC. EMRs were queried retrospectively to generate a de-identified
report including age, sex, admission diagnosis, pertinent medical history, medical or
surgical treatment for the current admission, and purpose for placement of the MLC to
determine characteristics of those who received MLCs.
SPSS was the software package used to calculate the Wilcoxon signed-rank test
results. This test was chosen because it enables an examination of the differences in two
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sets of data being compared as the data were from the same sources at different times and
because it accounts for the specific magnitude of those differences (Fields, 2013). SPSS
was the statistical package used to determine characteristics of patients who received
MLCs.
Findings and Implications
The findings from the Wilcoxon signed-rank test are for the CLABSI group A for
6 months (January – June, 2015) prior to use of MLCs; there were no differences
compared to those of CLABSI group B for 6 months (January – June, 2016) after MLCs
were introduced , z = .73, p = .463, r = 0.3. The findings from the Wilcoxon signed-rank
test are for the DUR group A for 6 months (January – June, 2015) prior to use of MLCs
were no different than those of DUR group B for 6 months (January – June, 2016) after
MLCs were introduced z = -1.79, p = .074, r = -.73. These results revealed no
significant differences in the two groups. The result of the Wilcoxon signed-rank test is
there is no difference in CLABSI rates and DUR when comparing 6 months before use of
MLCs to 6 months after use of MLCs.
The characteristics of those who received MLCs in the selected 6 months after the
initiation include 42.7% males and 57.3% female patients. Individuals receiving MLCs
ranged in age from 15 – 103 years with the mean age being 53.8 years. The highest
percentage of patients was in the 51 – 70 year old age group representing 37.4% of the
262 patients. The admission diagnoses including outpatient treatments for those who
received MLCs are noted below in Figure 1. Cardiovascular, neuro, and infection
admission diagnoses were noted in 43% of those who received MLCs. Sickle cell

22
diagnoses were characteristic in 12% of those who received MLCs. The “other” category
included electrolyte imbalances, such as hyponatremia and hypokalemia, as well as
diagnoses such as dementia, dehydration, hypertension, diabetic ketoacidosis,
electroconvulsive therapy (ECTs) for depression, and fever of unknown origin. Analysis
of the diagnoses revealed that, for those who received MLCs, 63.4% had predominantly
medical diagnoses throughout their stay and 36.6% had surgical diagnoses. MLCs were
inserted exclusively for IV access for therapy lasting more than 3 days.

Figure 1. A graphic representation of various categorical admission diagnoses and
outpatient treatment for the 262 patients who received MLCs from January – June 2016.
A de-identified characteristics report and above figure were created by the student with
data queried from the EMR.
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Unanticipated limitations included difficulty in obtaining a list of specific
diagnoses for the focused hospital stay. The EMR includes all diagnoses in the record for
all admissions and may have the same diagnoses listed in synonymous terms such as high
blood pressure and hypertension. The admission diagnosis was found to be the best
resource for type of medical or surgical admission although there were a few exceptions
such as burns which may or may not necessitate surgery. The potential impact on
findings may be the percentages of medical or surgical diagnoses may be skewed.
Implications resulting from the findings include providing clinical staff,
communities, institutions, and systems with information to support the use of MLCs in
populations of patients who have difficult IV access and need an alternative VAD to
provide IV therapy for up to 28 days (Alexandrou et al, 2011; Moureau & Chopra, 2016).
The use of MLCs may be initiated not only in the ICU but in clinical settings such as the
emergency department (ED) with better understanding of the characteristics of those
patients that may benefit from them (Adams et al., 2016). The community may benefit by
understanding MLCs may be used for home IV therapy or outpatient procedures such as
ECTs for depression (Giuliani et al., 2013; Griffiths, 2007).
Recommendations
The recommendations for practice are to examine a larger sample size to
determine if the comparison of 6 months prior to MLC use and 6 months after use may
have made a difference when comparing CLABSI rates and DUR. The characteristics of
those who have received MLCs may initiate evaluation for the use of these catheters for
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similar patients sooner in their treatment there by saving those individuals from multiple
IV attempts and there by preserving vessel health (Moureau et al., 2012). Characteristics
of patients who have received MLCs should be described in a larger population of
patients to determine if they may provide a useful alternative to other types VADs than
previously known.
Strengths and Limitations of the Project
The project poses questions that have not been studied in the literature in the same
way they have been in this DNP project. One strength of the project was having a single
clinical provider inserting MLCs which provided control of extraneous variables in
regard to careful adherence to guidelines and protocols when performing insertion. This
project had limitations including a small sample size and the majority of patients were
adults. The data was only gathered at one hospital rather than the whole hospital system
which would have provided a larger sample size with a greater variety of patient
characteristics. The time frame of 6 months for the study rather than examining a longer
period of time such as one or two years of data is also a limitation. The project would
have been more meaningful if the cases of those patients who had CLABSIs were able to
be correlated to the characteristics of age, gender, admission diagnoses and other active
diagnoses or current problems during the hospital episode. The CLABSI rates are
declining across the country due to initiatives from the CDC (CDC, 2016), although, if
unmonitored or with poor adherence to care bundles, such rates have a tendency to
increase (Matocha, 2013).
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Summary
The purpose of this study was to quantitatively compare CLABSI rates and DUR
6 months prior to and 6 months after the initiation of MLCs in one Southeastern Level I
Trauma Center and teaching hospital. The Wilcoxon signed-rank test was used for the
comparison and revealed no difference in CLABSI rates and DUR before and after
MLCs. Characteristics of the 262 patients who received MLCs were described as follows:
42.7% males; 57.3% females; age range was 15 – 103 years with a mean age of 53.8
years; 43% had admission diagnoses of cardiovascular, neuro, and infection; 63.4% were
treated for medical diagnoses; 36.6% were treated for surgical diagnoses; and 100%
received these devices for IV access needed for longer than 3 days. Implications of the
findings of this study include a better understanding of the purpose and use of MLCs and
characteristics of patients who may benefit from them.
Recommendations for future studies include comparing longer periods of time in
multiple hospitals to determine if there might be a difference observed in CLABSI rates
and DUR. Strengths and limitations of this project include a better understanding of the
use of MLCs in various clinical settings. Understanding patient characteristics may
encourage clinicians to use MLCs earlier in the hospital stay to save patients from
multiple IV attempts in difficult to access situations and to preserve vessels. A larger
population of patients may reveal other patient characteristics or populations that may
benefit from MLCs. Maintaining vigilance in the use of MLCs and choosing the correct
VAD for the right purpose and treatment will benefit all patient populations. Section 5
will provide the plan for dissemination of the study results.
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Section 5: Dissemination Plan
Dissemination
The results and recommendations learned from this project will be discussed with
educators and the IV team who were influential in the MLC program and DNP Project
process. A power point presentation will be created and shared by the student with
stakeholders. Applications will be completed for a minimum of two organizational
conferences to provide a poster presentation of the results for this project. The student
intends to apply for an article to be published in the future after completion of the Walden
DNP program. Nursing journals such as Journal of Vascular Access or American Journal
of Nursing will be queried for interest in this topic in order to disseminate the results to a
broader population of nursing professionals.

Analysis of Self
I have grown as a practitioner, scholar, project manager, and leader through this
DNP Project. A project manager must have broad vision of the project understanding the
overall goals, objectives, time frame for implementation, and evaluation methods needed
to measure the process and outcomes. Throughout the DNP program, leadership skills
have been cultivated by enhancing knowledge as a practitioner and a scholar. The DNP
program has given me a broader view of patient care and the many factors that influence
the ability to give evidence-based care including organizational, state, and national
politics (Montalvo & Byrne, 2016). My growth in politics and leadership was enhanced
by a number of mentors including a state nursing lobbyist, Director of Nursing
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Education, Director of Emergency Services, and Director of Nursing Research. The
experiences gained in leadership were enhanced by these mentors showing me how to
query various resources to have access to the most current and accurate information.
Politics and policies in the nation, state, and local areas have a tremendous impact on
how patients’ health care needs are met. I learned so much information about state
legislation and understand the importance of the need for DNPs to be involved in
leadership roles to influence access to care for all individuals and bring about social
change.
A DNP must have the ability to assess problems and know where to look to find
the best answers. DNPs generate internal evidence through quality improvement and
Evidence-Based Practice (EBP) projects. They then translate this evidence into practice
thereby enhancing health care quality and influencing health policy (Melnyk, 2013).
When the best evidence is found I feel confident in my ability to translate the evidence
into practice at the bedside, to improve patient care and outcomes, and to sustain the
change in practice for it to become the new norm (Stoeckel & Kruschke, 2013).
This DNP project has been challenging due to the complexity of the questions
being asked. The scholarly journey taken with this project has taught perseverance. The
completion of this DNP project has also enhanced my leadership and mentorship. While
working with the IV Team, many current issues in IV therapy have been discussed and
opportunities to learn from each other have been cultivated. Tools to help the bedside
staff retain skills and knowledge of protocols and MLC care management have been
developed. The project has given me confidence to translate evidence into practice in a
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manner that is welcomed and accepted by staff as well as empowered them with
knowledge of how to use this valuable tool.
Summary
The findings from this study will be disseminated through various methods
including poster and oral presentations. The DNP Project has provided the learner with an
un-parallel opportunity for growth in leadership, knowledge, confidence, and the ability
to become involved in health policy issues. This project was intended to examine the
MLC role in patient care. The MLC is another tool that can be used to manage care
effectively and efficiently for a targeted population of patients under the right
circumstances. The small CLABSI rates and DUR determined there was no difference
before MLC use when compared to the same measures for a similar period after
implementation of these devices. Patient characteristics of those who received MLCs
were described. The goal of this project was to help clinicians use MLCs for the best
population of patients, for the appropriate reasons, and to provide the best evidence based
care for patients as this is the role of the DNP.
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